tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

LYPHF Stock Latest News

Luye Pharma Gains Approval for Innovative Antidepressant Trials
Company AnnouncementsLuye Pharma Gains Approval for Innovative Antidepressant Trials
2d ago
Luye Pharma’s $100 Million Convertible Bonds Issuance
PremiumCompany Announcements
Luye Pharma’s $100 Million Convertible Bonds Issuance
12d ago
Luye Pharma Boosts Liquidity with $100M Bond Issue
PremiumCompany Announcements
Luye Pharma Boosts Liquidity with $100M Bond Issue
14d ago
Luye Pharma Adjusts Closing Date for Bond Issue
PremiumCompany Announcements
Luye Pharma Adjusts Closing Date for Bond Issue
16d ago
Luye Pharma Group to Issue $150M Convertible Bonds
PremiumCompany Announcements
Luye Pharma Group to Issue $150M Convertible Bonds
21d ago
Luye Pharma Group Reports Strong Mid-Year Financials
PremiumCompany AnnouncementsLuye Pharma Group Reports Strong Mid-Year Financials
3M ago
Luye Pharma Sets Date for Financial Results Review
Premium
Company Announcements
Luye Pharma Sets Date for Financial Results Review
3M ago
Luye Pharma Group Completes Key Investment Phase
Premium
Company Announcements
Luye Pharma Group Completes Key Investment Phase
3M ago
Luye Pharma’s Breakthrough Drug Enters Clinical Trials
PremiumCompany Announcements
Luye Pharma’s Breakthrough Drug Enters Clinical Trials
3M ago
Luye Pharma’s ERZOFRI Wins FDA Approval
PremiumCompany Announcements
Luye Pharma’s ERZOFRI Wins FDA Approval
4M ago
Luye Pharma Group Announces Major Investment Deal
PremiumCompany Announcements
Luye Pharma Group Announces Major Investment Deal
4M ago
Luye Pharma’s New Pain Drug Approved in China
PremiumCompany Announcements
Luye Pharma’s New Pain Drug Approved in China
4M ago
Luye Pharma’s LY03010 Clears FDA Inspection
PremiumCompany AnnouncementsLuye Pharma’s LY03010 Clears FDA Inspection
5M ago
Luye Pharma’s New Parkinson’s Drug Approved in China
Premium
Company Announcements
Luye Pharma’s New Parkinson’s Drug Approved in China
5M ago
Luye Pharma’s New Schizophrenia Treatment Approved
Premium
Company Announcements
Luye Pharma’s New Schizophrenia Treatment Approved
5M ago
Luye Pharma Expands Alzheimer’s Treatment into Japan
PremiumCompany Announcements
Luye Pharma Expands Alzheimer’s Treatment into Japan
5M ago
Luye Pharma Group’s AGM Concludes with Positive Outcomes
PremiumCompany Announcements
Luye Pharma Group’s AGM Concludes with Positive Outcomes
6M ago
Luye Pharma downgraded to Sell from Neutral at Goldman Sachs
PremiumThe Fly
Luye Pharma downgraded to Sell from Neutral at Goldman Sachs
10M ago
Luye Pharma upgraded to Neutral from Underperform at Credit Suisse
PremiumThe Fly
Luye Pharma upgraded to Neutral from Underperform at Credit Suisse
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >